$TBCH
Turtle Beach Corp

2024 Q3 Form 10-Q Financial Statement

#000095017024094160 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $94.36M $76.48M
YoY Change 59.51% 59.39%
Cost Of Revenue $60.23M $53.40M
YoY Change 45.25% 47.89%
Gross Profit $34.13M $23.08M
YoY Change 92.95% 94.37%
Gross Profit Margin 36.17% 30.17%
Selling, General & Admin $19.89M $21.20M
YoY Change 25.66% -9.68%
% of Gross Profit 58.27% 91.89%
Research & Development $4.311M $4.589M
YoY Change -1.58% 9.55%
% of Gross Profit 12.63% 19.89%
Depreciation & Amortization $3.322M $3.306M
YoY Change 174.55% 171.21%
% of Gross Profit 9.73% 14.33%
Operating Expenses $27.71M $27.19M
YoY Change 37.13% -1.73%
Operating Profit $6.423M -$4.111M
YoY Change -355.18% -73.97%
Interest Expense -$2.712M -$2.220M
YoY Change 2612.0% -13158.82%
% of Operating Profit -42.22%
Other Income/Expense, Net -$252.0K -$352.0K
YoY Change -47.61% 77.78%
Pretax Income $3.459M -$6.683M
YoY Change -211.4% -58.16%
Income Tax $46.00K $841.0K
% Of Pretax Income 1.33%
Net Earnings $3.413M -$7.524M
YoY Change -194.65% -52.74%
Net Earnings / Revenue 3.62% -9.84%
Basic Earnings Per Share $0.17 -$0.35
Diluted Earnings Per Share $0.16 -$0.35
COMMON SHARES
Basic Shares Outstanding 20.75M 21.52M
Diluted Shares Outstanding 21.50M 21.25M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.80M $12.46M
YoY Change 12.22% -21.06%
Cash & Equivalents $13.80M $12.46M
Short-Term Investments
Other Short-Term Assets $9.686M $11.38M
YoY Change 10.07% 27.48%
Inventory $102.3M $73.35M
Prepaid Expenses
Receivables $70.70M $46.47M
Other Receivables $0.00 $0.00
Total Short-Term Assets $196.5M $143.7M
YoY Change 50.02% 27.36%
LONG-TERM ASSETS
Property, Plant & Equipment $5.753M $6.295M
YoY Change 19.16% -52.33%
Goodwill $56.70M $56.76M
YoY Change 430.6% 431.18%
Intangibles $44.54M $46.68M
YoY Change 2154.25% 1985.92%
Long-Term Investments
YoY Change
Other Assets $1.173M $1.268M
YoY Change 67.57% 107.87%
Total Long-Term Assets $116.7M $120.7M
YoY Change 360.57% 351.49%
TOTAL ASSETS
Total Short-Term Assets $196.5M $143.7M
Total Long-Term Assets $116.7M $120.7M
Total Assets $313.2M $264.4M
YoY Change 100.38% 89.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $66.39M $48.38M
YoY Change 69.38% 42.14%
Accrued Expenses $25.87M $26.48M
YoY Change 39.11% 39.95%
Deferred Revenue
YoY Change
Short-Term Debt $58.63M $24.03M
YoY Change 340.8%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $155.7M $103.2M
YoY Change 109.08% 84.86%
LONG-TERM LIABILITIES
Long-Term Debt $45.70M $45.77M
YoY Change
Other Long-Term Liabilities $8.488M $8.611M
YoY Change 17.5% 15.69%
Total Long-Term Liabilities $54.18M $54.38M
YoY Change 650.06% 630.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $155.7M $103.2M
Total Long-Term Liabilities $54.18M $54.38M
Total Liabilities $211.4M $159.1M
YoY Change 151.94% 143.01%
SHAREHOLDERS EQUITY
Retained Earnings -$138.2M -$141.6M
YoY Change -3.22% 1.74%
Common Stock $20.00K $21.00K
YoY Change 17.65% 23.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $101.8M $105.3M
YoY Change
Total Liabilities & Shareholders Equity $313.2M $264.4M
YoY Change 100.38% 89.47%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $3.413M -$7.524M
YoY Change -194.65% -52.74%
Depreciation, Depletion And Amortization $3.322M $3.306M
YoY Change 174.55% 171.21%
Cash From Operating Activities -$23.17M -$12.64M
YoY Change 42.38% 164.57%
INVESTING ACTIVITIES
Capital Expenditures $1.425M $1.236M
YoY Change 112.69% 238.63%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$1.800M
YoY Change
Cash From Investing Activities -$1.425M -$3.036M
YoY Change 112.69% 731.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 24.49M 10.19M
YoY Change 79.8% 3835.52%
NET CHANGE
Cash From Operating Activities -23.17M -12.64M
Cash From Investing Activities -1.425M -3.036M
Cash From Financing Activities 24.49M 10.19M
Net Change In Cash -102.0K -5.487M
YoY Change -96.93% 12.32%
FREE CASH FLOW
Cash From Operating Activities -$23.17M -$12.64M
Capital Expenditures $1.425M $1.236M
Free Cash Flow -$24.59M -$13.88M
YoY Change 45.17% 169.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001493761
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssets
CY2024Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35465
dei Entity Registrant Name
EntityRegistrantName
TURTLE BEACH CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2767540
dei Entity Address Address Line1
EntityAddressAddressLine1
44 South Broadway
dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
White Plains
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10601
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
496-8001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20754274
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76478000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47982000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132326000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
99426000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
53402000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
36110000
us-gaap Cost Of Revenue
CostOfRevenue
91464000
us-gaap Cost Of Revenue
CostOfRevenue
73415000
CY2024Q2 us-gaap Gross Profit
GrossProfit
23076000
CY2023Q2 us-gaap Gross Profit
GrossProfit
11872000
us-gaap Gross Profit
GrossProfit
40862000
us-gaap Gross Profit
GrossProfit
26011000
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13741000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10351000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22754000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19874000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4589000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4189000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8491000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8290000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7463000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13125000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13137000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20132000
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1394000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6304000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
27187000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
27665000
us-gaap Operating Expenses
OperatingExpenses
50686000
us-gaap Operating Expenses
OperatingExpenses
48296000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4111000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15793000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9824000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22285000
CY2024Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2220000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
17000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2370000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-146000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-352000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-198000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-722000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-318000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6683000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15974000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12916000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22749000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
841000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5547000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-124000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-7524000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15920000
us-gaap Net Income Loss
NetIncomeLoss
-7369000
us-gaap Net Income Loss
NetIncomeLoss
-22625000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.34
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.93
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.34
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21252000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17156000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19795000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16869000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21252000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17156000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19795000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16869000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-7524000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15920000
us-gaap Net Income Loss
NetIncomeLoss
-7369000
us-gaap Net Income Loss
NetIncomeLoss
-22625000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
236000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-182000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
410000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
236000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-35000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-182000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
410000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7288000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15955000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7551000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22215000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12462000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18726000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46474000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54390000
CY2024Q2 us-gaap Inventory Net
InventoryNet
73347000
CY2023Q4 us-gaap Inventory Net
InventoryNet
44019000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11380000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7720000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
143663000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
124855000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6295000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4824000
CY2024Q2 us-gaap Goodwill
Goodwill
56762000
CY2023Q4 us-gaap Goodwill
Goodwill
10686000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46683000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1734000
CY2024Q2 us-gaap Other Assets
OtherAssets
10985000
CY2023Q4 us-gaap Other Assets
OtherAssets
7868000
CY2024Q2 us-gaap Assets
Assets
264388000
CY2023Q4 us-gaap Assets
Assets
149967000
CY2024Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
24029000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
48380000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
26908000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30827000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
29424000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
103236000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
56332000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
45772000
CY2024Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1508000
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1546000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8611000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7012000
CY2024Q2 us-gaap Liabilities
Liabilities
159127000
CY2023Q4 us-gaap Liabilities
Liabilities
64890000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20753358
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20753358
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17531702
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17531702
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
21000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
18000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
247917000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
220185000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-141646000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-134277000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1031000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-849000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
105261000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
85077000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
264388000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
149967000
us-gaap Net Income Loss
NetIncomeLoss
-7369000
us-gaap Net Income Loss
NetIncomeLoss
-22625000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2084000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1948000
hear Costs Recognized On Sale Of Acquired Inventory
CostsRecognizedOnSaleOfAcquiredInventory
1251000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2698000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
513000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
348000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
75000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1951000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6929000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6339000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-209000
hear Revenue From Contract With Customer Sales Returns Reserve For Sales Returns
RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns
3209000
hear Revenue From Contract With Customer Sales Returns Reserve For Sales Returns
RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns
2419000
us-gaap Inventory Write Down
InventoryWriteDown
2081000
us-gaap Inventory Write Down
InventoryWriteDown
-1098000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-32616000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-32685000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11238000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5457000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11281000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7452000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1300000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-691000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
192000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-261000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-10434000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4928000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14613000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24210000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1967000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1252000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
77294000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-79261000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1252000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
80288000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
99785000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
56259000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
118838000
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
50000000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
417000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2941000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1358000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15207000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
974000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3170000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
80000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58176000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18749000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
208000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
182000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6264000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4391000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18726000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11396000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12462000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15787000
us-gaap Interest Paid Net
InterestPaidNet
2224000
us-gaap Interest Paid Net
InterestPaidNet
226000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
159000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-137000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
85077000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
155000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-418000
CY2024Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
38050000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1257000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1105000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
125226000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-7524000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
236000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1684000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
846000
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
15207000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
105261000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
88941000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6705000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
445000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
124000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1959000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
84764000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15920000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-35000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1234000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4986000
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
974000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
74055000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">: The preparation of financial statements in conformity with generally accepted accounting principles requires management to use estimates and assumptions that affect the reported amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. The significant estimates and assumptions used by management affect: sales return reserve, allowances for cash discounts, warranty reserve, valuation of inventory, valuation of long-lived assets, goodwill and other intangible assets, depreciation and amortization of long-lived assets, valuation of deferred tax assets, probability of performance shares vesting and forfeiture rates utilized in issuing stock-based compensation awards. The Company evaluates estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from these estimates, and those differences could be material to the consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
62379000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
43579000
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
10968000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
440000
CY2024Q2 us-gaap Inventory Net
InventoryNet
73347000
CY2023Q4 us-gaap Inventory Net
InventoryNet
44019000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39731000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35740000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33436000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30916000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6295000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4824000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3009000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3944000
CY2024Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
6596000
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5275000
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
4350000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
5206000
CY2024Q2 hear Accrued Freight Current
AccruedFreightCurrent
2215000
CY2023Q4 hear Accrued Freight Current
AccruedFreightCurrent
2917000
CY2024Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1858000
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3335000
CY2024Q2 hear Accrued Expenses Current
AccruedExpensesCurrent
12799000
CY2023Q4 hear Accrued Expenses Current
AccruedExpensesCurrent
8747000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30827000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
29424000
CY2024Q2 hear Finite Lived Intangible Assets Foreign Currency Gross
FiniteLivedIntangibleAssetsForeignCurrencyGross
1189000
CY2024Q2 hear Finite Lived Intangible Assets Foreign Currency Accumulated Amortization
FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization
1214000
CY2024Q2 hear Finite Lived Intangible Assets Foreign Currency Net
FiniteLivedIntangibleAssetsForeignCurrencyNet
-25000
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
59615000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12932000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46683000
CY2023Q4 hear Finite Lived Intangible Assets Foreign Currency Gross
FiniteLivedIntangibleAssetsForeignCurrencyGross
1159000
CY2023Q4 hear Finite Lived Intangible Assets Foreign Currency Accumulated Amortization
FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization
1292000
CY2023Q4 hear Finite Lived Intangible Assets Foreign Currency Net
FiniteLivedIntangibleAssetsForeignCurrencyNet
-133000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
11876000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10142000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1734000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1900000
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1900000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2700000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4299000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
8016000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
7761000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
7591000
CY2024Q2 hear Finite Lived Intangible Assets Amortization Expense After Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree
18991000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46658000
CY2023Q4 us-gaap Goodwill
Goodwill
10686000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
46076000
CY2024Q2 us-gaap Goodwill
Goodwill
56762000
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
24029000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
49583000
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
2200000
us-gaap Interest Expense Debt
InterestExpenseDebt
2700000
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
100000
us-gaap Interest Expense Debt
InterestExpenseDebt
200000
CY2024Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
300000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
300000
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
33000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
75000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
841000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5547000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-124000
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.126
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.003
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.429
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
CY2024Q2 hear Unrecognized Tax Benefits Inclusive Of Interest And Penalties
UnrecognizedTaxBenefitsInclusiveOfInterestAndPenalties
2800000
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
600000
CY2019Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000
CY2021Q2 srt Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2023-04-09
CY2023Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P2Y
CY2024Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1000000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1000000
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
15200000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
15200000
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
846000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4970000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1951000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6929000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1059000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
703000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1041452
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.1
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y2M19D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3137285
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
346842
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
824
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
60.87
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
693786
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.45
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M6D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4060476
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
695434
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.53
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y10M6D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4060476
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
693421
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y10M6D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4060476
hear Sharebased Compensation Arrangement By Sharebased Payment Award Forfeiture Period After Ending Employment
SharebasedCompensationArrangementBySharebasedPaymentAwardForfeiturePeriodAfterEndingEmployment
P90D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2300000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1200000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-7524000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15920000
us-gaap Net Income Loss
NetIncomeLoss
-7369000
us-gaap Net Income Loss
NetIncomeLoss
-22625000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21252000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17156000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19795000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16869000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21252000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17156000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19795000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16869000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.34
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.93
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.34
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1978000
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2821000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2046000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2794000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76478000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47982000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132326000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
99426000
CY2020Q2 hear Number Of Shareholders
NumberOfShareholders
8
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
687000
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
616000
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
670000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
618000
CY2024Q2 us-gaap Product Warranty Expense
ProductWarrantyExpense
263000
CY2023Q2 us-gaap Product Warranty Expense
ProductWarrantyExpense
190000
us-gaap Product Warranty Expense
ProductWarrantyExpense
483000
us-gaap Product Warranty Expense
ProductWarrantyExpense
375000
CY2024Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
215000
CY2023Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
166000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
418000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
353000
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
735000
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
640000
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
735000
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
640000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9717000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2108000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7714000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9822000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
us-gaap Operating Lease Payments
OperatingLeasePayments
900000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1174000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2360000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2314000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2284000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1282000
CY2024Q2 hear Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2007000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11421000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1599000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9822000

Files In Submission

Name View Source Status
0000950170-24-094160-index-headers.html Edgar Link pending
0000950170-24-094160-index.html Edgar Link pending
0000950170-24-094160.txt Edgar Link pending
0000950170-24-094160-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hear-20240630.htm Edgar Link pending
hear-20240630.xsd Edgar Link pending
hear-20240630_htm.xml Edgar Link completed
hear-ex10_5.htm Edgar Link pending
hear-ex31_1.htm Edgar Link pending
hear-ex31_2.htm Edgar Link pending
hear-ex32_1.htm Edgar Link pending
img253761762_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable